SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon shines as its arm receives Rs 555 crore capital injection from ADQ

08 Jan 2021 Evaluate

Biocon is currently trading at Rs. 464.40, up by 9.45 points or 2.08% from its previous closing of Rs. 454.95 on the BSE.

The scrip opened at Rs. 466.00 and has touched a high and low of Rs. 467.70 and Rs. 461.65 respectively. So far 62793 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 487.70 on 23-Dec-2020 and a 52 week low of Rs. 235.80 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 471.20 and Rs. 453.00 respectively. The current market cap of the company is Rs. 54594.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.98% and 16.35% respectively.

Biocon’s subsidiary -- Biocon Biologics (BBL) has received approval from its board for a primary equity investment by Abu Dhabi based ADQ (ADQ), one of the region’s largest holding companies. As per the terms of the proposed agreement, ADQ will invest Rs 555 crore for a 1.80% minority stake in the biosimilar business, valuing Biocon Biologics at a post money valuation of around $4.17 billion.

The transaction is subject to customary condition precedents and approvals. Post the completion of this transaction, Biocon will hold 89.89% stake in Biocon Biologics on a fully diluted basis.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

365.10 4.70 (1.30%)
05-May-2026 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.80
Dr. Reddys Lab 1281.90
Cipla 1322.25
Zydus Lifesciences 909.90
Lupin 2351.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×